OVITRELLE sol inj 250 mcg/0.5 ml ser pré 0.5 ml
7680563640078
CH-56364
G03GA08
07.08.1.
Reimbursement limitations:
070810 NEU
N'est pas remboursé pour le traitement de l'obésité.
Remboursement uniquement après examen endocrinologique et …
1 / 3
google
Details
- Product number
- 5636401
- CPT
- -
- Packaging group
- 1
- Unit
- Spritze(n)
- Composition
- choriogonadotropinum alfa 250 µg, poloxamerum 188, mannitolum, acidum phosphoricum concentratum, natrii hydroxidum corresp. natrium 0.1 mg, methioninum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.
Articles (1)
Ovitrelle 250 µg, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.1 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | ANTOX |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 49.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2004
Authorization holder
Merck (Schweiz) AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 56364
- Drug name
- Ovitrelle 250 µg, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- G03GA08
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 17/02/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 07.08.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OVITRELLE sol inj 250 mcg/0.5 ml ser pré 0.5 ml
- Description (DE)
- OVITRELLE Inj Lös 250 mcg/0.5 ml Fertspr 0.5 ml
- Market launch
- 17/02/2004
- Narcotic (BTM)
- No